author-photo

Thomas Danne

Hannover Medical School

22

Papers

618

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial.

2021 Pediatric Diabetes
Show All
- Source
- Cite
- Save
Citations (2)
Ultra Rapid Lispro (URLi) Showed Greater Reduction in Postprandial Glucose (PPG) vs Lispro in Children, Adolescents, and Adult Patients with Type 1 Diabetes (T1D)

2021
Show All
- Source
- Cite
- Save
Citations (0)
A worldwide perspective on COVID-19 and diabetes management in 22,820 children from the SWEET project: diabetic ketoacidosis rates increase and glycemic control is maintained.

2021 Diabetes Technology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes.

2021 Diabetes Technology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (7)
Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial.

2020 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (4)
Lower Risk for Severe Hypoglycaemia with Insulin Glargine 300 U/mL vs Glargine 100 U/mL in Participants with Type 1 Diabetes: a Meta-Analysis of 6-Month Phase 3 Clinical Trials.

2020 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (8)
Dose‐Dependent Glycometabolic Effects of Sotagliflozin on Type 1 Diabetes Over 12 Weeks: the inTandem4 Trial

2019 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (10)
International consensus on use of continuous glucose monitoring

2018
Show All
- Source
- Cite
- Save
Citations (32)
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

2018 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (104)
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

2018 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (79)